+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Home-based Ophthalmic Monitoring Solutions, 2020

  • Report

  • 36 Pages
  • October 2020
  • Region: Global
  • Frost & Sullivan
  • ID: 5187564

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema require continuous monitoring of eye health, as they can be treated if detected early, but if left undetected, it can silently and rapidly progress to irreversible loss of vision.

Home-based ophthalmic monitoring solutions can help in preventing vision deterioration in patients with high risk of developing debilitating eye conditions by providing timely and early detection of warning signs with continuous monitoring of visual health, and also enabling better ocular disease management by tracking the effectiveness of therapy. Home monitoring solutions provide continuous data on the progress of the disease and also enhance compliance by increasing patient engagement. With the entry of home-based solutions in the ophthalmic space, eye hospitals and ophthalmologists have started adopting innovative business models. It is creating a transformative mega trend in the ophthalmology practice.


Table of Contents

1. Strategic Imperative and Growth Environment
  • Strategic Imperative
  • Growth Environment


2. The Radar™ Home-based Ophthalmic Monitoring Solutions
3. Companies to Action:
  • Notal Vision
  • EyeQue Corporation
  • Implandata Ophthalmic Products
  • Revenio Group
  • SENSIMED
  • Oculocare Medical
  • Genentech
  • GLANCE Optical Pty. Ltd.
  • EyeLab Ltd.
  • Kubota Vision
  • Injectsense
  • Qura


4. Strategic Insights
5. Next Steps: Leveraging the The Radar™ to Empower Key Stakeholders
  • Significance of Being on the The Radar™
  • The Radar™ Empowers the CEO’s Growth Team
  • The Radar™ Empowers Investors
  • The Radar™ Empowers Customers
  • The Radar™ Empowers the Board of Directors


6. The Radar™ Analytics
  • The Radar™: Benchmarking Future Growth Potential
  • Legal Disclaimer

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • EyeLab Ltd.
  • EyeQue Corporation
  • GLANCE Optical Pty. Ltd.
  • Genentech
  • Implandata Ophthalmic Products
  • Injectsense
  • Kubota Vision
  • Notal Vision
  • Oculocare Medical
  • Qura
  • Revenio Group
  • SENSIMED